Bone dysplasia

Feuillan PP et al. (1986) Treatment of precocious puberty in the McCune-Albright syndrome with the aromatase inhibitor testolactone.

None (1970) Bones, stones and hormones: the contributions of Fuller Albright.

Shires R et al. (1979) Idiopathic hypothalamic hypogonadotropic hypogonadism with polyostotic fibrous dysplasia.

McArthur RG et al. (1979) Albright's syndrome with rickets.

Hall R et al. (1972) Hypersecretion of hypothalamic releasing hormones: a possible explanation of the endocrine manifestations of polyostotic fibrous dysplasia (Albright's syndrome).

None (1986) The McCune-Albright syndrome: a lethal gene surviving by mosaicism.

Giovannelli G et al. (1978) McCune-Albright syndrome in a male child: a clinical and endocrinologic enigma.

Kaplan FS et al. (1988) Estrogen receptors in bone in a patient with polyostotic fibrous dysplasia (McCune-Albright syndrome).

Viljoen DL et al. (1988) Polyostotic fibrous dysplasia with cranial hyperostosis: new entity or most severe form of polyostotic fibrous dysplasia?

None (1988) Osteosarcoma in fibrous dysplasia.

Schey WL et al. (1971) Familial pubic bone maldevelopment.

Döhler JR et al. (1986) Idiopathic hyperphosphatasia with dermal pigmentation. A twenty-year follow-up.

Ehrich JH et al. (1990) Association of spondylo-epiphyseal dysplasia with nephrotic syndrome.

Abs R et al. (1990) Acromegaly, multinodular goiter and silent polyostotic fibrous dysplasia. A variant of the McCune-Albright syndrome.

Zacharin M et al. (2011) Gastrointestinal polyps in McCune Albright syndrome.

Hamilton CR et al. (1973) Unusual types of hyperthyroidism.

None (1977) Fibrous dysplasia of bone. Report of female monozygotic twins with and without the McCune-Albright syndrome.

Feuillan PP et al. (1991) Luteinizing hormone-releasing hormone (LHRH)-independent precocious puberty unresponsive to LHRH agonist therapy in two girls lacking features of the McCune-Albright syndrome.

Weinstein LS et al. (1991) Activating mutations of the stimulatory G protein in the McCune-Albright syndrome.

Elizondo LI et al. (2009) Schimke immuno-osseous dysplasia: SMARCAL1 loss-of-function and phenotypic correlation.

Hashimoto K et al. (1994) Juvenile variant of Schimke immunoosseous dysplasia.

Boerkoel CF et al. (1998) Schimke immunoosseous dysplasia complicated by moyamoya phenomenon.

Kaitila I et al. (1998) Autoimmune enteropathy in Schimke immunoosseous dysplasia.

Bianco P et al. (1998) Reproduction of human fibrous dysplasia of bone in immunocompromised mice by transplanted mosaics of normal and Gsalpha-mutated skeletal progenitor cells.

None (1998) "A rare disorder, yes; an unimportant one, never".

Dent CE et al. (1976) Hypophosphataemic osteomalacia in fibrous dysplasia.

Mastorakos G et al. (1997) Hyperthyroidism in McCune-Albright syndrome with a review of thyroid abnormalities sixty years after the first report.

None (1993) Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 7-1993. A six-year-old boy with multiple bone lesions, repeated fractures, and sexual precocity.

Ludman MD et al. (1993) Schimke immuno-osseous dysplasia: case report and review.

Santavá A et al. (1994) Spondyloepiphyseal dysplasia with nephrotic syndrome (Schimke immunoosseous dysplasia).

Taha D et al. (2004) Fatal lymphoproliferative disorder in a child with Schimke immuno-osseous dysplasia.

Malchoff CD et al. (1994) An unusual presentation of McCune-Albright syndrome confirmed by an activating mutation of the Gs alpha-subunit from a bone lesion.

Candeliere GA et al. (1995) Increased expression of the c-fos proto-oncogene in bone from patients with fibrous dysplasia.

Cole DE et al. (1983) Panostotic fibrous dysplasia: a congenital disorder of bone with unusual facial appearance, bone fragility, hyperphosphatasemia, and hypophosphatemia.

Alvarez-Arratia MC et al. (1983) A probable monogenic form of polyostotic fibrous dysplasia.

Nager GT et al. () Fibrous dysplasia of the temporal bone. Update with case reports.

Comite F et al. (1984) Cyclical ovarian function resistant to treatment with an analogue of luteinizing hormone releasing hormone in McCune-Albright syndrome.

None (1966) Sex precocity and polyostotic fibrous dysplasia. Report of a case in a boy with testicular biopsy.

Firat D et al. (1968) Fibrous dysplasia of the bone. Review of twenty-four cases.

Wirth WA et al. (1971) Multiple intramuscular myxomas. Another extraskeletal manifestation of fibrous dysplasia.

de Sanctis C et al. () McCune-Albright syndrome: a longitudinal clinical study of 32 patients.

None (1975) Editorial: Albright syndrome: is it coming of age?

Laven JS et al. (2001) Dynamics of ovarian function in an adult woman with McCune--Albright syndrome.

Obuobie K et al. (2001) McCune-Albright syndrome: growth hormone dynamics in pregnancy.

Coutant R et al. (2001) Macroorchidism due to autonomous hyperfunction of Sertoli cells and G(s)alpha gene mutation: an unusual expression of McCune-Albright syndrome in a prepubertal boy.

Petty EM et al. (2000) Successful bone marrow transplantation in a patient with Schimke immuno-osseous dysplasia.

None (2000) Dental findings in the Schimke immuno-osseous dysplasia.

Sigurdardottir S et al. (2000) Mental retardation and seizure disorder in Schimke immunoosseous dysplasia.

Boerkoel CF et al. () Manifestations and treatment of Schimke immuno-osseous dysplasia: 14 new cases and a review of the literature.

Bianco P et al. (2000) Mutations of the GNAS1 gene, stromal cell dysfunction, and osteomalacic changes in non-McCune-Albright fibrous dysplasia of bone.

Mieszczak J et al. (2008) The aromatase inhibitor anastrozole is ineffective in the treatment of precocious puberty in girls with McCune-Albright syndrome.

Reitzik M et al. (1975) Familial polyostotic fibrous dysplasia.

Saraiva JM et al. (1999) Schimke immuno-osseous dysplasia: case report and review of 25 patients.

Kitoh H et al. (1999) Different genotype of periosteal and endosteal cells of a patient with polyostotic fibrous dysplasia.

Kirk JM et al. (1999) Cushing's syndrome caused by nodular adrenal hyperplasia in children with McCune-Albright syndrome.

Tinschert S et al. (1999) McCune-Albright syndrome: clinical and molecular evidence of mosaicism in an unusual giant patient.

Spranger J et al. (1991) Schimke immuno-osseous dysplasia: a newly recognized multisystem disease.

Clewing JM et al. (2007) Schimke immunoosseous dysplasia: suggestions of genetic diversity.

Clewing JM et al. (2007) Schimke immuno-osseous dysplasia: a clinicopathological correlation.

Boerkoel CF et al. (2002) Mutant chromatin remodeling protein SMARCAL1 causes Schimke immuno-osseous dysplasia.

Lou S et al. (2002) Longevity in Schimke immuno-osseous dysplasia.

Baradaran-Heravi A et al. (2008) Clinical and genetic distinction of Schimke immuno-osseous dysplasia and cartilage-hair hypoplasia.

Endo M et al. (1991) Monozygotic twins discordant for the major signs of McCune-Albright syndrome.

Lücke T et al. (2007) Cerebellar atrophy in Schimke-immuno-osseous dysplasia.

Yoshimoto M et al. (1991) A case of neonatal McCune-Albright syndrome with Cushing syndrome and hyperthyroidism.

Feuillan P et al. (2007) Letrozole treatment of precocious puberty in girls with the McCune-Albright syndrome: a pilot study.

Schwindinger WF et al. (1991) DNA light on the Tegernsee giant.

Nerlich A et al. (1991) Juvenile gigantism plus polyostotic fibrous dysplasia in the Tegernsee giant.

Elizondo LI et al. (2006) Schimke immuno-osseous dysplasia: a cell autonomous disorder?

Schwindinger WF et al. (1992) Identification of a mutation in the gene encoding the alpha subunit of the stimulatory G protein of adenylyl cyclase in McCune-Albright syndrome.

Lumbroso S et al. (2004) Activating Gsalpha mutations: analysis of 113 patients with signs of McCune-Albright syndrome--a European Collaborative Study.

Lücke T et al. (2004) Generalized atherosclerosis sparing the transplanted kidney in Schimke disease.

Laven JS et al. (2004) Management of infertility in a patient presenting with ovarian dysfunction and McCune-Albright syndrome.

Plotkin H et al. (2003) Effect of pamidronate treatment in children with polyostotic fibrous dysplasia of bone.

Premawardhana LD et al. (1992) Acromegaly and its treatment in the McCune-Albright syndrome.

Cremonini N et al. (1992) Atypical McCune-Albright syndrome associated with growth hormone-prolactin pituitary adenoma: natural history, long-term follow-up, and SMS 201-995--bromocriptine combined treatment results.

None (1992) Tegernsee giant.

HIBBS RE et al. (1952) [Albright's syndrome].

Collins MT et al. (2003) Thyroid carcinoma in the McCune-Albright syndrome: contributory role of activating Gs alpha mutations.

Akintoye SO et al. (2002) Characterization of gsp-mediated growth hormone excess in the context of McCune-Albright syndrome.

Orphanet article